Academic Awards

In an industry where speed and precision can determine the success of lifesaving therapies, pharmaceutical firms are increasingly turning to enterprise resource planning (ERP) systems to modernize operations. These platforms unify core functions, including supply chain management, manufacturing, and financial planning and analysis (FP&A), providing teams with real-time data visibility, regulatory control, and enhanced agility. Below, we examine five key areas where ERP systems are transforming pharmaceutical operations and delivering impactful results. 1. Improved Agility And Risk Management Traditional supply chains, which are often heavily dependent on fragmented systems and manual coordination, struggled to adapt during recent global disruptions. In contrast, cloud-based ERP platforms now enable pharmaceutical firms to model various scenarios, reallocate resources, and respond more quickly when conditions change. For example, when a major supplier shutdown occurred during the pa...

  When astronomers first discovered exoplanets, they found massive ones orbiting large stars. The technology to detect smaller planets around low-mass, dim red dwarfs took time to develop. By the mid-2000s, HARPS (High Accuracy Radial velocity Planet Searcher) was specifically targeting M dwarfs and in 2009 discovered the least massive exoplanet at the time. In 2016, the CARMENES instrument joined the effort and began its survey of M dwarf stars. It's mounted on the Spanish Calar Alto telescope and its mission is to examine about 300 M dwarfs for signs of Earth-like exoplanets. CARMENES uses the radial velocity method to detect planets tugging on their stars, and so far has discovered many short-orbit exoplanets around stars with masses below 0.34 solar masses. New research in Astronomy and Astrophysics announces the discovery of more Earth-like planets around even lower mass stars. It's titled "The CARMENES search for exoplanets around M dwarfs: Occurrence rates of Earth-...